SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Halyard He...
June 29 2016 - 6:08PM
Rigrodsky & Long, P.A.:
- Do you, or did you, own shares of Halyard Health,
Inc. (NYSE:HYH) or Kimberly-Clark
Corporation (NYSE:KMB)?
- Did you purchase your shares of Halyard Health, Inc.
between October 21, 2014 and April 29, 2016,
inclusive?
- Did you purchase your shares of Kimberly-Clark
Corporation on or after February 25, 2013 and subsequently received
Halyard Health, Inc. securities pursuant to Kimberly-Clark
Corporation’s spin-off of Halyard Health, Inc., effective as of
October 31, 2014?
- Did you lose money in your investment?
Rigrodsky & Long, P.A. announces that a
complaint has been filed in the United States District Court for
the Southern District of New York on behalf of all persons or
entities that purchased the common stock of Halyard Health, Inc.
(“Halyard” or the “Company”) (NYSE:HYH) between October 21, 2014
and April 29, 2016, inclusive, and/or purchased the common stock of
Kimberly-Clark Corporation (“Kimberly-Clark”) (NYSE:KMB) on or
after February 25, 2013 and subsequently received Halyard
securities pursuant to Kimberly-Clark’s spin-off of Halyard,
effective as of October 31, 2014 (collectively, the “Class
Period”), alleging violations of the Securities Exchange Act of
1934 against the Company and certain of its officers (the
“Complaint”).
If you purchased shares of Halyard or
Kimberly-Clark during the Class Period, and wish to discuss this
action or have any questions concerning this notice or your rights
or interests, please contact Timothy J. MacFall, Esquire or Peter
Allocco of Rigrodsky & Long, P.A., 2 Righter Parkway, Suite
120, Wilmington, DE 19803 at (888) 969-4242; by e-mail to
info@rl-legal.com; or at:
http://rigrodskylong.com/investigations/halyard-health-inc-hyh-kmb.
The Complaint alleges that throughout the Class Period, defendants
made materially false and misleading statements, and omitted
materially adverse facts, about the Company’s business, operations
and prospects. Specifically, the Complaint alleges that the
defendants concealed that: (1) the Company’s MICROCOOL surgical
gowns consistently failed effectiveness tests and failed to meet
industry standards; and (2) Kimberly-Clark and Halyard had
knowingly provided defective MICROCOOL surgical gowns to U.S.
workers during the Ebola crisis. As a result of defendants’
alleged false and misleading statements, the Company’s stock traded
at artificially inflated prices during the Class Period.
On May 1, 2016, 60 Minutes reported that
Kimberly-Clark and Halyard had knowingly provided defective
surgical gowns to U.S. workers at the height of the Ebola crisis.
A Company insider claimed that Halyard’s MICROCOOL surgical
gowns were prone to leaks and did not consistently meet the
industry safety standards for the treatment of Ebola, but that
Kimberly-Clark and Halyard had nonetheless “aggressively” marketed
the MICROCOOL gowns to hospitals during the epidemic.
On this news, shares of Halyard dropped 4.3%,
closing at $26.95 per share on May 2, 2016, on heavy trading
volume.
If you wish to serve as lead plaintiff, you must
move the Court no later than August 29,
2016. A lead plaintiff is a representative party
acting on behalf of other class members in directing the
litigation. Any member of the proposed class may move the
court to serve as lead plaintiff through counsel of their choice,
or may choose to do nothing and remain an absent class member.
Attorney advertising. Prior results do not guarantee a
similar outcome.
CONTACT:
Rigrodsky & Long, P.A.
Timothy J. MacFall, Esquire
Peter Allocco
(888) 969-4242
(516) 683-3516
Fax: (302) 654-7530
info@rl-legal.com
http://www.rigrodskylong.com
Kimberly Clark (NYSE:KMB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kimberly Clark (NYSE:KMB)
Historical Stock Chart
From Apr 2023 to Apr 2024